# US 2024/0197806 A1 · Ebelin lactone or bacogenin a1 enriched composition and method of preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197806 A1
- Document ID: US20240197806A1
- Status: Published application
- Kind: A1
- Application number: 17/988,617
- Filed: 2022-11-16
- Published: 2024-06-20
- Earliest claimed: 2022-11-16
- Applicants: Supplement Holdings, LLC; Network Nutrition Pty Limited
- Inventors: Paul Eftang; Emiel Bakker; James Jursich; Ryan Gorman
- Web page: https://patentgrep.com/patent/US20240197806A1

## CPC

- A61K 36/68: Plantaginaceae (Plantain Family)
- A61K 36/80: Scrophulariaceae (Figwort family)
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K 2236/33: involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K 2236/39: Complex extraction schemes, e.g. fractionation or repeated extraction steps
- A61P 25/00: Drugs for disorders of the nervous system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present disclosure provides a method of preparing an ebelin lactone or bacogenin A1 enriched composition from acid-hydrolyzed extract of Bacopa monnieri. Also provided is a composition prepared by the method. Advantageously, the present method may yield a cost effective product containing at least 10% ebelin lactone, which may result in an entirely new subjective experience with fully hydrolyzed Bacopa monnieri extract.

## Claims

### Claim 1

A method for preparing an ebelin lactone or bacogenin A1 enriched composition, the method comprising contacting an acid-hydrolyzed extract of Bacopa monnieri with an antisolvent, thereby precipitating the ebelin lactone or bacogenin A1 enriched composition.

### Claim 2 (depends on 1)

The method of claim 1, wherein contacting the acid-hydrolyzed extract with the antisolvent increases pH.

### Claim 3 (depends on 1)

The method of claim 1, wherein the antisolvent is an aqueous antisolvent.

### Claim 4 (depends on 1)

The method of claim 1, further comprising drying and milling the precipitate.

### Claim 5 (depends on 4)

The method of claim 4, wherein the dried and milled precipitate has an ebelin lactone content of at least 10%.

### Claim 6 (depends on 1)

The method of claim 1, wherein the acid-hydrolyzed extract of Bacopa monnieri is prepared by:
washing pulverized Bacopa monnieri thereby forming a wash-insoluble fraction;
drying the wash-insoluble fraction to a moisture content below a predetermined value;
extracting, with a polar protic extractant, bacosides from the dried wash-insoluble fraction;
concentrating the extract, wherein the concentrated extract has a bacoside content above a predetermined value;
hydrolyzing the concentrated extract with an acidified solvent, thereby forming the acid-hydrolyzed extract of Bacopa monnieri.

### Claim 7 (depends on 6)

The method of claim 6, wherein contacting the acid-hydrolyzed extract with the antisolvent increases pH.

### Claim 8 (depends on 6)

The method of claim 6, wherein the antisolvent is an aqueous antisolvent.

### Claim 9 (depends on 6)

The method of claim 6, wherein the acidified solvent comprises a polar protic solvent and a mineral acid.

### Claim 10 (depends on 9)

The method of claim 9, wherein the polar protic solvent is methanol or ethanol.

### Claim 11 (depends on 9)

The method of claim 9, wherein the mineral acid is sulfuric acid.

### Claim 12 (depends on 6)

The method of claim 6, wherein the predetermined moisture content is at least 15%.

### Claim 13 (depends on 6)

The method of claim 6, wherein the polar protic extractant comprises methanol.

### Claim 14 (depends on 6)

The method of claim 6, wherein the predetermined bacoside content is at least 20%.

### Claim 15 (depends on 6)

The method of claim 6, wherein the extract is concentrated by drying.

### Claim 16 (depends on 6)

The method of claim 6, wherein the pulverized Bacopa monnieri is washed with an aqueous wash.

### Claim 17 (depends on 6)

The method of claim 6, wherein the extract is filtered prior to concentration.

### Claim 18 (depends on 1)

The method of claim 1, wherein the acid-hydrolyzed extract of Bacopa monnieri is prepared by:
washing, with an aqueous wash, pulverized Bacopa monnieri, thereby forming a wash-insoluble fraction;
drying the wash-insoluble fraction to a moisture content below 15%;
extracting, with a polar protic extractant comprising methanol, bacosides from the dried wash-insoluble fraction;
filtering the extract,
concentrating the filtered extract, wherein the concentrated extract has a bacoside content above 20%;
hydrolyzing the concentrated extract with an acidified solvent comprising a polar protic solvent and a mineral acid, thereby forming the acid-hydrolyzed extract of Bacopa monnieri.

### Claim 19 (depends on 1)

The composition prepared by the method according to claim 1.

### Claim 20 (depends on 19)

The composition of claim 19, wherein the precipitate after drying has an ebelin lactone content of at least 10%.

### Claim 21 (depends on 6)

The composition prepared by the method according to claim 6.

### Claim 22 (depends on 21)

The composition of claim 21, wherein the precipitate after drying has an ebelin lactone content of at least 10%.

### Claim 23 (depends on 18)

The composition prepared by the method according to claim 18.

### Claim 24 (depends on 21)

The composition of claim 21, wherein precipitate after drying has an ebelin lactone content of at least 10%.

### Claim 25 (depends on 19)

A pharmaceutical composition comprising an effective amount of the composition according to claim 19 and a pharmaceutically acceptable carrier.

### Claim 26 (depends on 19)

A nutraceutical composition comprising the composition according to claim 19 and a nutraceutically acceptable carrier.

### Claim 27 (depends on 19)

A method of treating a subject in need of ebelin lactone or bacogenin A1, the method comprising administering an effective amount of the composition according to claim 19 to the subject.
